FDA Inspection 1276137 — Biomat Holdings Mount Vernon Newark

Biomat Holdings Mount Vernon Newark — FEI 3029965162

The FDA completed an inspection of Biomat Holdings Mount Vernon Newark on Jul 15, 2025 in Newark, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 15, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Newark, OH (United States)

Citations

IDCFRDescription
33321 CFR 640.64(e)Prevention of contamination

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.